• Wondering if Ameren's current share price offers good value or if you are late to the party? This article walks through the key numbers so you can judge the valuation for yourself.
• With the stock at US$109.92 after a 2.1% move over the last week, a 3.0% decline over 30 days, and returns of 9.0% year to date and 12.3% over 1 year, the recent pattern gives mixed signals about how the market is pricing Ameren today.
• Recent coverage has focused on Ameren's role within the utilities sector and how investors are weighing its income profile and perceived stability against changing expectations for interest rates and regulation. This context is important because shifts in those expectations often feed directly into how investors assess the fair value of a regulated utility.
• Ameren currently holds a value score of 2 out of 6, which suggests only a couple of standard valuation checks point to the stock being undervalued. Next up is a look at how methods like DCFs, P/E and dividend based approaches stack up, before finishing with a simple way to pull all of this into one clearer valuation picture.

Ameren scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Ameren Dividend Discount Model (DDM) Analysis

The Dividend Discount Model estimates what a stock might be worth by projecting its future dividends and discounting them back to today, then comparing that value with the current share price.

For Ameren, the model uses a dividend per share of about US$3.37, a return on equity of 10.46% and a payout ratio of roughly 57.47%. That payout level suggests a little over half of earnings are being returned to shareholders as dividends, with the rest retained in the business. The DDM growth rate is set at 3.41%, capped from a higher initial figure of 4.45%, while the broader expected growth input in the model is 4.45%.

Using these assumptions in the DDM produces an estimated intrinsic value of about US$94.33 per share. Compared with the current share price of US$109.92, this implies the stock is about 16.5% above the DDM estimate. On this specific dividend based framework, Ameren appears to be trading at an overvalued level.

Result: OVERVALUED

Our Dividend Discount Model (DDM) analysis suggests Ameren may be overvalued by 16.5%. Discover 58 high quality undervalued stocks or create your own screener to find better value opportunities.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Ameren.

Approach 2: Ameren Price vs Earnings

P/E is a useful yardstick for a profitable utility because it links what you are paying directly to the earnings the business is already generating. In simple terms, higher growth expectations or lower perceived risk usually support a higher P/E, while slower growth or higher perceived risk tend to justify a lower, more conservative multiple.

Ameren currently trades on a P/E of about 20.9x. That sits above the Integrated Utilities industry average of around 19.2x, but below the peer group average of roughly 23.0x. Simply Wall St’s Fair Ratio for Ameren is 24.1x, which represents the P/E level suggested by its model after factoring in elements such as earnings growth, profit margins, industry, market cap and specific company risks.

This Fair Ratio can be more informative than a plain comparison with peers or the broad industry because it adjusts for those company specific characteristics rather than assuming all utilities should trade on the same multiple. Set against the current P/E of 20.9x, the Fair Ratio of 24.1x indicates that Ameren is trading at a discount on this earnings based yardstick.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Ameren Narrative

Earlier we mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St's Community page let you link your view of Ameren's story to a set of forecast numbers and a fair value. You can then compare that fair value with the current price and see it update as news or earnings arrive. This is why some investors might align with a more optimistic narrative closer to US$132.00, while others lean toward a more cautious US$104.00 view, even though the consensus sits at US$117.00.

Do you think there's more to the story for Ameren? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.